HUMAN TISSUE ACQUISITION AND PATHOLOGY
HUMAN TISSUE ACQUISITION AND PATHOLOGY
批准号:
8376824
负责人:
Gustavo Enrique Ayala
金额:
$13.67万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AdvocateAreaBasic ScienceBenchmarkingBiological PreservationBiopsyBreastBreast LymphomaBudgetsCancer CenterColonConsentCooperative Human Tissue NetworkCost AnalysisDataDatabasesDiagnosticDrug or chemical Tissue DistributionElectronicsEmergency SituationFreezingFrozen SectionsFutureGeneral HospitalsGenomeGenomicsGuidelinesHematoxylin and Eosin Staining MethodHistologicHistological TechniquesHistologyHospitalsHuman ResourcesImmunohistochemistryIndividualLaboratoriesLanguageMaintenanceMalignant neoplasm of ovaryMedicineMethodologyOffice of Administrative ManagementOnline SystemsOperating RoomsPancreasParaffinPathologistPathologyPatientsPediatric HospitalsProceduresProcessProstateProstate LymphomaQuality ControlRNARecontactsRectumRelative (related person)Reproduction sporesResearchResearch PersonnelResource SharingResourcesServicesSpecimenSystemTabletsTechnologyTexasTissue BankingTissue BanksTissue ModelTissuesTranslatingTranslational ResearchTumor BankVendorVeteransbasecollegecostcost effectiveexperiencehuman diseasehuman tissueinstrumentationinterestmemberoperationprogramstwo-dimensional
中文摘要
人类组织获取和病理共享资源(HTAP)是DLDCC最大的共享资源之一。目的是提供复杂的组织学技术,并为癌症中心的成员提供组织。共享资源主任和主要人员在组织获取、组织库维护和分发以及资源提供的各种组织学服务方面拥有丰富的经验。HTAP有两项主要服务:组织获取和分发和组织学服务。HTAP肿瘤库和分发服务是建立在以前存在的肿瘤库的基础上的
英文摘要
The Human Tissue Acquisition and Pathology Shared Resource (HTAP) is one of the largest Shared Resources for the DLDCC. The purpose is to offer sophisticated histologic techniques and to provide tissues to Cancer Center members. The Shared Resource director and key personnel have extensive experience in tissue acquisition, bank maintenance and distribution, and the various histologic services offered by the Resource, The HTAP has 2 major services: Tissue Acquisition and Distribution and Histology Services, The HTAP tumor banking and distribution services were built on the basis of previously existing tumor banks at
BCM that began over 20 years ago. These include general tumor banks at the Ben Taub General Hospital Michael DeBakey VA hospital and Texas Children's Hospital; the Baylor Breast, Prostate and Lymphoma Spore banks, as well as banks in the fields of pancreas, colon and rectum, and ovarian cancers. They now have been rolled into the DLDCC HTAP and are integrated not only at the level of standard operating procedures (SOPs) and guidelines for distribution of tissues, but also in the administrative management of personnel and budgets. This synchronization of resources and efforts results in a synergistic operation that provides cost effective services, increased tumor banking accruals, better reliability and quality and a more fair distribution system. Tissue acquisition has almost tripled. Since 2006 we have also deployed a new proactive tissues acquisition system were "patient tissue advocate" is responsible not only for consenting, but for the acquisition and prompt transfer of tissues. Tissues are now banked frozen, paraffin, and for RNA preservation. Tissues are characterized and data entered into a newly established tissue bank database. We are implementing 2 dimensional barcoding and have established emergency backup systems for storage freezers. The histology services have all been centralized in a research exclusive histology laboratory under the HTAP. By centralizing our laboratory services and making this an exclusive research enterprise we have achieved stability of resources and services and cost efficiency relative to outside vendors or small individual research or departmental driven laboratories. Furthermore, by pooling instrumentation we provide better access to specialized technologies, methodologies and unique services that are specific to our cancer center. Histology has provided services to 33 investigators. We have also acquired and distributed tissues throughout programs in the DLDCC. In the future we plan to expand our banking efforts to diagnostic biopsies and expand our databasing efforts to include electronic tablet consenting.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Comprehensive Tumor Microenvironment Based Prediction Models in Prostate Cancer
-
批准号:8109106
-
项目类别:
-
资助金额:$32.47万
-
财政年份:2011
-
负责人:Gustavo Enrique Ayala
-
依托单位:
Comprehensive Tumor Microenvironment Based Prediction Models in Prostate Cancer
-
批准号:8504754
-
项目类别:
-
资助金额:$29.58万
-
财政年份:2011
-
负责人:Gustavo Enrique Ayala
-
依托单位:
Comprehensive Tumor Microenvironment Based Prediction Models in Prostate Cancer
-
批准号:8676696
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2011
-
负责人:Gustavo Enrique Ayala
-
依托单位:
InForm image segmentation image analysis software and Vectra automation system
-
批准号:7790887
-
项目类别:
-
资助金额:$35.35万
-
财政年份:2010
-
负责人:Gustavo Enrique Ayala
-
依托单位:
HUMAN TISSUE ACQUISITION AND PATHOLOGY
-
批准号:8180989
-
项目类别:
-
资助金额:$15.47万
-
财政年份:2010
-
负责人:Gustavo Enrique Ayala
-
依托单位:
Neurogenesis in the Prostate Cancer Microenvironment
-
批准号:7244459
-
项目类别:
-
资助金额:$12.0万
-
财政年份:2006
-
负责人:Gustavo Enrique Ayala
-
依托单位:
HUMAN TISSUE ACQUISITION AND PATHOLOGY
-
批准号:8690554
-
项目类别:
-
资助金额:$12.68万
-
财政年份:--
-
负责人:Gustavo Enrique Ayala
-
依托单位:
HUMAN TISSUE ACQUISITION AND PATHOLOGY
-
批准号:8296125
-
项目类别:
-
资助金额:$14.01万
-
财政年份:--
-
负责人:Gustavo Enrique Ayala
-
依托单位:
Neurogenesis in the Prostate Cancer Microenvironment
-
批准号:8128542
-
项目类别:
-
资助金额:$16.97万
-
财政年份:--
-
负责人:Gustavo Enrique Ayala
-
依托单位:
Neurogenesis in the Prostate Cancer Microenvironment
-
批准号:7494162
-
项目类别:
-
资助金额:$25.21万
-
财政年份:--
-
负责人:Gustavo Enrique Ayala
-
依托单位:
HUMAN TISSUE ACQUISITION AND PATHOLOGY
-
批准号:8515960
-
项目类别:
-
资助金额:$19.61万
-
财政年份:--
-
负责人:Gustavo Enrique Ayala
-
依托单位:
Neurogenesis in the Prostate Cancer Microenvironment
-
批准号:7687278
-
项目类别:
-
资助金额:$19.07万
-
财政年份:--
-
负责人:Gustavo Enrique Ayala
-
依托单位:
Neurogenesis in the Prostate Cancer Microenvironment
-
批准号:7896567
-
项目类别:
-
资助金额:$27.58万
-
财政年份:--
-
负责人:Gustavo Enrique Ayala
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: